vermillion inc (VRML:NASDAQ CM)

Executive Profile*

Background*

Dr. John P. Cooke, M.D., Ph.D. is a Professor in the Division of Cardiovascular Medicine, and Associate Director (Education and Training) of the Stanford Cardiovascular Institute at Stanford University School of Medicine. At Stanford, Dr. Cooke spearheads the programme in Vascular Biology and Medicine and directs a translational research programme in vascular biology from molecule to man, focused on endothelial biology, angiogenesis and vascular regeneration. He is a ... founder and served as President of the US Society for Vascular Medicine. He has served as the Principal Investigator for numerous clinical trials. He was a Member of the professoriate at Harvard Medical School. He serves as a Member of the Scientific Advisory Board of CoMentis Inc. (Formerly, Athenagen Inc.). Dr. Cooke has been a Member of Clinical Advisory Board at ReNeuron Group plc since February 2010. He has been a Member of Scientific Advisory Board at Vermillion, Inc. since March 2010. He serves as Member of the Clinical Advisory Board of Angiogenix, Inc. He served as Member of Scientific Advisory Board of Pluristem Therapeutics, Inc., since June 2, 2009. He is a Member of the Vascular Trialists. He serves on US national and international committees that deal with cardiovascular diseases, including those of the American Heart Association, American College of Cardiology, and the US National Heart, Lung and Blood Institute. He is an author of over 350 scientific articles in vascular medicine and biology. He trained in Cardiovascular Medicine at the Mayo Clinic. Dr. Cooke holds an MD degree from Wayne State University, Detroit, and PhD in Physiology from the Mayo Graduate School of Medicine, Rochester, MN.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
VRML:US	$2.55 USD	-0.08

COMPETITOR COMPENSATION